-
1 Comment
RadNet, Inc is currently in a long term uptrend where the price is trading 56.5% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
RadNet, Inc's total revenue rose by 2.4% to $308M since the same quarter in the previous year.
Its net income has dropped by 42.7% to $6M since the same quarter in the previous year.
Finally, its free cash flow grew by 60.4% to $25M since the same quarter in the previous year.
Based on the above factors, RadNet, Inc gets an overall score of 4/5.
Exchange | NASDAQ |
---|---|
CurrencyCode | USD |
ISIN | US7504911022 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Market Cap | 4B |
---|---|
PE Ratio | 1225.25 |
Beta | 1.59 |
Target Price | 71.6667 |
Dividend Yield | None |
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for RDNT using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025